Nutromics banks A$7.5m to make its ‘lab-on-a-patch’ device in Australia
Melbourne medtech startup Nutromics has raised A$7.5 million in an acceleration round, taking total funding to about A$60 million.
Nutromics is developing a wearable “lab-on-a-patch” device that uses DNA biosensors and microneedles to capture continuous, real-time molecular data.
“Our world first clinical study, completed in 2024, showed successful results”, said Nutromics CEO and co-founder Peter Vranes. “We’re now conducting ICU trials, a global first for this class of wearable diagnostics.
